oral tirzepatide effectiveness The infographic compares 10 commonly discussed weight-loss medicines. and semaglutide produce the greatest average loss, but they can cause nausea, vomiting, constipation, gallstones and Oral tirzepatide drops reviews: what

How research frames these peptides The clinical picture draws on the STEP program for semaglutide (published in The New England Journal of Medicine , 2021) and the SURMOUNT and SURMOUNT-OSA programs for tirzepatide (NEJM 2022 and 2024)

This isnt a reason to categorically rule it out, but it is a reason to have a thorough conversation with a gastroenterologist who understands EDS, ideally before starting, not after problems develop

The front or outer thigh works well

Longer-acting injectable formulations are also in development

Symptoms are usually mild to moderate and may include loose or watery stools, urgency, or more frequent bowel movements

When administered properly, it is generally considered safe